Endometriosis Market by Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End Users (Hospitals, Homecare, Speciality Centers, and Others), and Region 2023-2028

Endometriosis Market by Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End Users (Hospitals, Homecare, Speciality Centers, and Others), and Region 2023-2028

Report Format: PDF+Excel | Report ID: SR112023A6676
Buy Now

Market Overview:

The global endometriosis market size reached US$ 2.26 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.13 Billion by 2028, exhibiting a growth rate (CAGR) of 5.40% during 2023-2028. The rising awareness about symptoms and diagnosis, the easy availability of various generic drugs, and the increasing number of clinical trials represent some of the key factors driving the market.

Endometriosis is a medical disorder wherein tissue similar to the lining of the uterus develops outside of the uterine cavity, fallopian tubes, ovaries, vagina, bladder, rectum, and diaphragm. It causes ovarian cysts, superficial lesions, deeper nodules, adhesions, and scar tissue within the body. It is associated with severe, life-impacting pain during the menstrual cycle, sexual intercourse, bowel movements, and urination. It also causes chronic pelvic pain, abdominal bloating, nausea, fatigue, depression, anxiety, and infertility. It is diagnosed through laparoscopy and rectovaginal examination to identify uterosacral and septal nodules. Endometriosis can be treated using hormone therapy, involving injections, nasal sprays and pills, medications, and surgical treatments to reduce pain and prevent infertility.

Endometriosis Market Trends:

The increasing prevalence of endometriosis represents one of the major factors strengthening the market growth around the world. Moreover, thegrowing demand for minimally invasive (MI) surgical procedures is influencing the market positively. In addition, there is a rise in awareness about endometriosis, its symptoms and diagnosis, and the easy availability of the treatment. This, coupled with the increasing consciousness among women about personal health and hygiene, is contributing to the market growth. Apart from this, the growing adoption of health insurance policies that provide financial assistance for endometriosis treatment and minimize healthcare expenses is creating a positive outlook for the market. Furthermore, governments of numerous countries are financing research and development (R&D) activities to identify therapeutic agents. This, along with the increasing number of clinical trials by pharmaceutical companies, is facilitating the market growth. Besides this, the easy availability of various generic drugs for relieving pain associated with endometriosis and the rising inclination towards postoperative pain management and palliative care services offered in numerous countries are propelling the growth of the market. They generally involve nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Motrin) and naproxen (Naprosyn), progestin, and gonadotropin-releasing hormone (GnRH) agonists that are available over the counter (OTC) and by prescription as pills, liquids, gels, and patches. Additionally, significant improvements in the healthcare infrastructure and diagnostic technologies are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global endometriosis market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, diagnosis and treatment, and end users.

Type Insights:

  • Superficial Peritoneal Lesion
  • Endometrioma
  • Deeply Infiltrating Endometriosis
  • Others
     

The report has also provided a detailed breakup and analysis of the endometriosis market based on the type. This includes superficial peritoneal lesion, endometrioma, deeply infiltrating endometriosis, and others.

Diagnosis and Treatment Insights:

  • Diagnosis
    • Ultrasound
    • Pelvic Exam
    • Laparoscopy
    • Magnetic Resonance Imaging (MRI)
    • Hysteroscopy
    • Sonohysterography
  • Treatment
    • Hormonal Therapy
    • Pain Management
    • Conservative Surgery
       

A detailed breakup and analysis of the endometriosis market based on the diagnosis and treatment has also been provided in the report. This includes diagnosis (ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography) and treatment (hormonal therapy, pain management, and conservative surgery).

End Users Insights:

  • Hospitals
  • Homecare
  • Speciality Centers
  • Others
     

A detailed breakup and analysis of the endometriosis market based on the end users has also been provided in the report. This includes hospitals, homecare, specialty centers, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for endometriosis. Some of the factors driving the North America endometriosis market included the growing demand for minimally invasive (MI) surgical procedures, well-established healthcare infrastructure, improved diagnostic technologies, and research and development (R&D) activities for introducing novel therapies, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global endometriosis market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, AbbVie Inc., Bayer AG, Debiopharm Group, Gedeon Richter Plc, Kissei Pharmaceutical Co. Ltd., Myovant Sciences GmbH, Sanofi S.A., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
    Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Type, Diagnosis and Treatment, End Users, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AbbVie Inc., Bayer AG, Debiopharm Group, Gedeon Richter Plc, Kissei Pharmaceutical Co. Ltd., Myovant Sciences GmbH, Sanofi S.A., Teva Pharmaceutical Industries Ltd., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global endometriosis market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global endometriosis market?
  • What are the key regional markets?
  • Which countries represent the most attractive endometriosis markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the diagnosis and treatment?
  • What is the breakup of the market based on the end users?
  • What is the competitive structure of the global endometriosis market?
  • Who are the key players/companies in the global endometriosis market?
     

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the endometriosis market from 2017-2028.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global endometriosis market.
  • The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the endometriosis industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Endometriosis Market by Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End Users (Hospitals, Homecare, Speciality Centers, and Others), and Region 2023-2028
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Clients Testimonial

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More